Conference
A phase II study of patupilone in patients (pts) with metastatic castration- resistant prostate cancer (CRPC) who have progressed after docetaxel
Abstract
5139
Authors
Beardsley EK; Saad F; Eigl B; Venner P; Hotte S; Winquist E; Ko YJ; Sridhar SS; Chi KN
Volume
27
Pagination
pp. 5139-5139
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2009
DOI
10.1200/jco.2009.27.15_suppl.5139
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X